Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +387%, ahead of Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%). Figures as of 20 Nov 2026, 11:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+387%
- Median
- +22.1%
- Combined market value
- DKK 25.47T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +387% | DKK 34B | DKK 96.96 | 3.34% up | 387% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +302% | DKK 63.2B | DKK 665.69 | 3.77% down | 302% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +233% | DKK 45.1B | DKK 665.28 | 1.91% up | 233% up | ||
| 4 | VeradermicsMANE · Health Care | +230% | DKK 35.8B | DKK 848.15 | 0.38% down | 230% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +176% | DKK 27.5B | DKK 201.01 | 1.24% up | 176% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | +105% | DKK 32.6B | DKK 578.41 | 1.01% up | 105% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +103% | DKK 66.9B | DKK 442.38 | 1.88% down | 103% up | ||
| 8 | ViatrisVTRS · Health Care | +90.1% | DKK 155.4B | DKK 135.55 | 1.97% down | 90% up | ||
| 9 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | DKK 59.3B | DKK 2,119.87 | 1.87% up | 83% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | DKK 30.7B | DKK 280.72 | 0.48% down | 82% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | DKK 50.8B | DKK 145.85 | 2.24% down | 79% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +74.0% | DKK 265.5B | DKK 461.75 | 1.38% down | 74% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | DKK 55.2B | DKK 845.63 | 2.47% down | 45% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | DKK 39.1B | DKK 1,956.50 | 3.94% down | 44% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | +39.2% | DKK 31.6B | DKK 329.33 | 3.86% down | 39% up | ||
| 16 | Merck & CoMRK · Health Care | +35.9% | DKK 2.23T | DKK 905.57 | 3.61% down | 36% up | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | DKK 42.5B | DKK 651.24 | 3.27% up | 35% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +31.0% | DKK 4.38T | DKK 1,821.50 | 2.04% down | 31% up | ||
| 19 | Eli LillyLLY · Health Care | +27.5% | DKK 8.21T | DKK 9,212.63 | 2.29% down | 28% up | ||
| 20 | Bristol-Myers SquibbBMY · Health Care | +26.1% | DKK 813.1B | DKK 397.79 | 2.05% down | 26% up | ||
| 21 | Belite BioBLTE · Health Care | +25.3% | DKK 41.8B | DKK 1,029.73 | 3.33% down | 25% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | DKK 651.3B | DKK 6,295.80 | 2.35% down | 22% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | DKK 900.1B | DKK 3,550.13 | 2.94% down | 22% up | ||
| 24 | AbbVieABBV · Health Care | +20.0% | DKK 3.42T | DKK 1,933.32 | 0.86% down | 20% up | ||
| 25 | Elanco Animal HealthELAN · Health Care | +18.2% | DKK 89.6B | DKK 179.26 | 1.54% down | 18% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +17.7% | DKK 162.4B | DKK 3,812.23 | 3.16% down | 18% up | ||
| 27 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | DKK 55.2B | DKK 796.40 | 1.88% down | 15% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | +14.8% | DKK 103.8B | DKK 533.07 | 0.22% up | 15% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | DKK 81.1B | DKK 418.79 | 0.02% down | 12% up | ||
| 30 | PfizerPFE · Health Care | +9.98% | DKK 1.07T | DKK 187.78 | 1.85% down | 10% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | DKK 42.1B | DKK 297.63 | 1.25% up | 8% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -9.21% | DKK 48.7B | DKK 925.14 | 1.25% up | 9% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -15.9% | DKK 48.5B | DKK 443.07 | 4.15% down | 16% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -18.9% | DKK 1.23T | DKK 708.24 | 0.58% down | 19% down | ||
| 35 | CytokineticsCYTK · Health Care | -21.4% | DKK 48.9B | DKK 350.88 | 0.27% up | 21% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -24.5% | DKK 32.9B | DKK 189.15 | 0.25% down | 25% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -25.7% | DKK 33.2B | DKK 397.69 | 3.16% down | 26% down | ||
| 38 | InsmedINSM · Health Care | -27.3% | DKK 216.1B | DKK 985.00 | 20.58% up | 27% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -27.6% | DKK 62.8B | DKK 2,705.18 | 0.34% down | 28% down | ||
| 40 | ZoetisZTS · Health Care | -33.8% | DKK 223.8B | DKK 550.87 | 5.59% down | 34% down | ||
| 41 | Summit TherapeuticsSMMT · Health Care | -34.7% | DKK 57.6B | DKK 72.07 | 0.67% up | 35% down | ||
| 42 | Legend BiotechLEGN · Health Care | -42.8% | DKK 21.3B | DKK 109.78 | 0.92% down | 43% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -64.2% | DKK 30.9B | DKK 185.60 | 0.62% down | 64% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.1% | DKK 135B | DKK 1,007.91 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8185 DKK).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+387%), Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 11:51 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of DKK 25.47T as of 20 Nov 2026, 11:51 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.